Stoke Therapeutics (STOK) Change in Receivables (2024 - 2026)

Stoke Therapeutics' Change in Receivables history runs 3 years deep, the most recent figure standing at -$1.5 million for Q1 2026.

• In Q1 2026, Change in Receivables fell 212.15% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at -$3.8 million (changed N/A YoY), while the FY2025 annual figure was $4.3 million, up 8436.0% from the prior year.
• Change in Receivables was -$1.5 million for Q1 2026 at Stoke Therapeutics, up from -$3.3 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $1.3 million in Q1 2025 to a low of -$3.3 million in Q4 2025.
• Historically, Change in Receivables has averaged -$942750.0 across 3 years, with a median of -$892000.0 in 2024.
• The sharpest annual moves came in 2025 and 2026: Change in Receivables tumbled 1011.41% in 2025, then tumbled 212.15% in 2026.
• A 3-year view of Change in Receivables shows it stood at -$298000.0 in 2024, then sank by 1011.41% to -$3.3 million in 2025, then surged by 55.13% to -$1.5 million in 2026.
• The last three Change in Receivables figures came in at -$1.5 million (Q1 2026), -$3.3 million (Q4 2025), and $1.3 million (Q1 2025), per Business Quant data.